- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Demand for Long-Acting Contraception Increased in Wake of Concerns About Birth Control Access
In the 30 days after the 2016 presidential election, demand for long-acting reversible contraceptives increased more than 20% compared with the same time the previous year.
In the 30 days after President Donald Trump was elected in 2016, demand for long-acting reversible contraception (LARC) was on the rise, according to new research published in JAMA Internal Medicine.
In the month after the election, rates of insertion for intrauterine devices and implants were up 21.6% compared with the same time the previous year.
“Our study tells us something important about women’s health preferences in a changing political climate,” author Lydia Pace, MD, MPH, of Harvard Medical School and Brigham and Women’s Hospital, said in a statement. “Women responded to this political event by seeking out this method of contraception, perhaps because the threat of losing access expedited a decision or encouraged them to seek out a method they hadn’t previously considered.”
The authors used the IBM/Truven MarketScan Analytics Commercial Claims and Encounters Database to study women between the ages of 39 and 45 who were enrolled in commercial insurance in the month before and the month after November 8 in both 2015 and 2016.
A total of 3,449,445 women in 2015 and 3,253,703 women in 2016 were included who had similar demographic and health plan characteristics. In 2015, the mean adjusted daily LARC insertion rate was 12.9 per 100,000 women on and before November 8 and 13.7 after. In 2016, the change was more apparent: the LARC insertion rate before the 2016 election was 13.4 per 100,000 compared with 16.3 per 100,000 women after.
“If our findings were projected to the approximately 33 million women in the US in this age range with employer-sponsored health insurance, this would correspond to 700 additional insertions per day in association with the 2016 election,” said Pace. “The changes in rate that we report here could reflect women’s concerns about losing contraceptive coverage under the Trump administration.”
In April 2018, experts at the annual meeting of American College of Obstetricians and Gynecologists highlighted barriers to access of LARC, including geography, payer coverage, and health institutions. The results of a survey of residents across the country found that training is an issue, with 8% of chief residents saying they had never inserted a contraceptive implant. In addition, religious affiliation of the institution was a barrier in the Midwest.
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
Addressing Maternal Mortality in Medicaid by Focusing on Mental Health
February 15th 2023On this episode of Managed Care Cast, we speak with Inland Empire Health Plan, a managed care plan serving more than 1.4 million residents on Medi-Cal in California, about a new maternal mental health program aimed at supporting new mothers, both before they give birth and afterward.
Listen
For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management
May 10th 2022On this episode of Managed Care Cast, we speak with Joanne Armstrong, MD, MPH, vice president and chief medical officer for Women’s Health and Genomics at CVS Health, on the distinct pathophysiology of cardiovascular disease in women and how her own health experiences have influenced her perspective on cardiovascular disease management.
Listen
What We’re Reading: Historic Low of Uninsured; Youth Gender Treatments; Birth Control Recall
August 4th 2023A record low of 7.7% of Americans had no health insurance at the start of 2023; the American Academy of Pediatrics renewed its backing of gender care for children while requesting a research review; 2 lots of an oral contraceptive were recalled for possible reduction in effectiveness.
Read More
Lawyers were questioned in a federal lawsuit intending to overturn approval of a drug used for medication abortion; during the COVID-19 pandemic in 2021, US maternal mortality increased for the third year in a row; the Alzheimer’s Association is lobbying Congress to push for Medicare coverage of new Alzheimer drugs under early access.
Read More
